Loading
Loading…
Loading…
| # | Company | Amount | Rank | Status |
|---|---|---|---|---|
| 1 | L1₹6.74Admitted-Finance | ₹6.74 | L1 | Admitted-Finance |
| 2 | L2₹7.16+₹0.42 (6.23%)Admitted-Finance | ₹7.16+₹0.42 (6.23%) | L2 | Admitted-Finance |
| 3 | L3₹30.74+₹24 (356.1%)Admitted-Finance | ₹30.74+₹24 (356.1%) | L3 | Admitted-Finance |
| 4 | L4₹36.17+₹29.43 (436.6%)Admitted-Finance | ₹36.17+₹29.43 (436.6%) | L4 | Admitted-Finance |
| 5 | L5₹39.74+₹33 (489.6%)Admitted-Finance C 21 22 23 SECTOR 3 NOIDA GB NAGAR UP UNICURE INDIA LTD NOIDA SECTOR 3 GAUTAM BUDH NAGAR GAUTAM BUDDHA NAGAR UTTAR PRADESH 201301 | GAUTAM BUDDHA NAGAR | UTTAR PRADESH | 201301 | ₹39.74+₹33 (489.6%) | L5 | Admitted-Finance |
| Sl No | Description | Qty | Unit | Reliance Life Sciences Pvt. Ltd L24 | ABBOTT INDIA LIMITED L6 | Indian Immunologicals Limited L12 | Novo Nordisk India Private Limited L23 | Midas Care Pharmaceuticals Pvt.Ltd. L9 | UNICURE INDIA LTD L5 | Ipca Laboratories Limited L1 | HEALTH BIOTECH LIMITED L20 | Cipla Ltd L8 | Alpa Laboratories Limited L2 | ITNAS PHARMACEUTICALS LTD L21 | Cadila Pharmaceuticals Limited L17 | MSD PHARMACEUTICALS PRIVATE LIMITED L25 | SAMKEM L3 | Grifols India Healthcare Private Limited L19 | CHIRON BEHRING VACCINES PRIVATE LIMITED L11 | United Biotech Pvt.Ltd. L13 | Biocon Biologics Limited L10 | Takeda Biopharmaceuticals India Private Limited L18 | Promea Therapeutics Private Limited L22 | Nixi Laboratories Pvt. Ltd. L16 | Mitra Industries Pvt. Ltd. L14 | Vantive Healthcare Pvt Ltd L15 | Pace Biotech L4 | Shree Krishnakeshav Laboratories Ltd L7 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1.00 | Lignocaine (A) + Adrenaline (B) Injection 2% (A) + 1:200000 (5 mcg/ml) (B) 30 ml Vial | 1 | 30 ml Vial | - | - | - | - | - | - | - | 11.52 ₹12.1 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 2.00 | Glycopyrrolate Injection 0.2 mg/ml 1 ml amp | 1 | 1 ml amp | - | - | - | - | - | - | - | 4.35 ₹4.57 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 3.00 | Sugammadex Injection 100 mg/ ml 2 ml VIAL | 1 | 2 ml VIAL | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 4.00 | Methotrexate Tablet 7.5 mg
1x10 | 1 | Tab. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 5.00 | Betamethasone Injection 4 mg/ml 1 ml Amp | 1 | 1 ml Amp | - | - | - | - | - | - | - | 3.8 ₹3.99 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 6.00 | N-acetylcysteine Tablet 600 mg 1x10 | 1 | Tab. | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 7.00 | Neostigmine Injection 0.5 mg/ml 1 ml Amp | 1 | 1 ml Amp | - | - | - | - | - | - | - | 4.35 ₹4.57 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 8.00 | Lorazepam Injection 2 mg/ml 1 ml Amp | 1 | 1 ml Amp | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 9.00 | Magnesium sulphate Injection 500 mg/ml 10 ml Vial | 1 | 10 ml Vial | - | - | - | - | - | - | - | 10.16 ₹10.67 Lowest | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| 10.00 | Sodium valproate Injection 100 mg/ml 5 ml Vial | 1 | 5 ml Vial | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Tender Value
₹73.3 Cr
EMD Value
₹1.5 Cr
Closing Date
22 Jun 2026, 2:00 pmClosed
MD, AMSCL
AMSCL
ROCUREMENT OF DRUGS UNDER EDL/SDL DRUGS LIST VIA RATE CONTRACT
2026_HFWD_52455_1
ROCUREMENT OF DRUGS UNDER EDL/SDL DRUGS LIST VIA RATE CONTRACT
Open Tender
Medicines
Item Rate
60 days
AMSCL
Please refer Tender documents.
2 documents required · 2 mandatory
₹2,000
Yes
₹1.5 Cr
Yes
AMSCL
30 Jul 2026
22 May 2026
22 Jun 2026
22 May 2026
22 Jun 2026
6 Jun 2026
22 May 2026 - 29 May 2026
29 May 2026
| Sl No | Description | Qty | Unit | Est. Rate | Est. Amount |
|---|---|---|---|---|---|
| 1 | Lignocaine (A) + Adrenaline (B) Injection 2% (A) + 1:200000 (5 mcg/ml) (B) 30 ml Vial | 1 | 30 ml Vial | - | - |
| 2 | Glycopyrrolate Injection 0.2 mg/ml 1 ml amp | 1 | 1 ml amp | - | - |
| 3 | Sugammadex Injection 100 mg/ ml 2 ml VIAL | 1 | 2 ml VIAL | - | - |
| 4 | Methotrexate Tablet 7.5 mg
1x10 | 1 | Tab. | - | - |
| 5 | Betamethasone Injection 4 mg/ml 1 ml Amp | 1 | 1 ml Amp | - | - |
| 6 | N-acetylcysteine Tablet 600 mg 1x10 | 1 | Tab. | - | - |
| 7 | Neostigmine Injection 0.5 mg/ml 1 ml Amp | 1 | 1 ml Amp | - | - |
| 8 | Lorazepam Injection 2 mg/ml 1 ml Amp | 1 | 1 ml Amp | - | - |
| 9 | Magnesium sulphate Injection 500 mg/ml 10 ml Vial | 1 | 10 ml Vial | - | - |
| 10 | Sodium valproate Injection 100 mg/ml 5 ml Vial | 1 | 5 ml Vial | - | - |
stage.html
html • 0.07 MB
tech_eval.pdf
boq_comp_chart.xlsx
xlsx
Tap a document below to read it instantly. You can also download everything as a ZIP if you prefer.
details.html
html • 0.03 MB
Tendernotice_1.pdf
PDF • 0.54 MB
etender86D.pdf
Tender Documents • 2.24 MB
BOQ_82924.xls
BOQ • 0.49 MB
Exte2.pdf
PDF • 0.76 MB
Corrigendum2.pdf
PDF • 0.74 MB
corrigendum1.pdf
PDF • 3.06 MB
corrigendum1.pdf
PDF • 3.06 MB
Download all tender documents and submit your bid
Disclaimer: TenderKart has made every reasonable effort to ensure that the information on this page is accurate and authentic, however it cannot be held liable for any third-party claims or losses or any damages. TenderKart makes no warranty, expressed or implied, as to the results obtained from the use of this information. If you notice any error or omission, please let us know at .